Overview
Tibial adamantinoma is a rare, low-grade malignant neoplasm primarily affecting the tibia, characterized by its complex histogenesis with evidence supporting both epithelial and eccrine differentiation origins 12.Diagnosis
Immunohistochemical markers: Positive for keratin, negative for factor VIII-related antigen, supporting epithelial origin 12.
Electron microscopy: Reveals desmosomes and intermediate-sized filaments indicative of epithelial differentiation 2.
Enzyme histochemical techniques: Demonstrates eccrine differentiation when compared to normal eccrine gland controls 2.Management
Surgical resection: Primary treatment often involves wide surgical excision to achieve clear margins 2.
Adjuvant therapy: Limited evidence; may consider based on tumor extent and risk factors, though specific drug classes and doses are not detailed in the provided abstracts 2.Special Populations
Elderly: Management considerations may include surgical feasibility and overall health status, though specific guidance is not provided 1.Key Recommendations
Confirm diagnosis using immunohistochemical markers, particularly keratin positivity and absence of factor VIII-related antigen (Evidence: Moderate 12).
Employ electron microscopy and enzyme histochemical techniques to support epithelial and eccrine differentiation in diagnosis (Evidence: Moderate 2).
Prioritize wide surgical resection for treatment, with adjuvant therapy considered on a case-by-case basis (Evidence: Expert opinion 2).References
1 Muretto P, Raspugli P. "Angioblastic" adamantinoma of the tibia. An immunohistochemical study. Tumori 1985. link
2 Eisenstein W, Pitcock JA. Adamantinoma of the tibia. An eccrine carcinoma. Archives of pathology & laboratory medicine 1984. link